Go to deals
TMT

London Stock Exchange has welcomed Pathos Communications to AIM

Pathos Communications plc, the technology-enabled, human-led public relations company, has completed a successful fundraising and admission to the Alternative Investment Market (AIM). The company’s ordinary shares will begin trading under the ticker NEWS at 08:00 GMT on 16 December 2025.

Pathos Communications was established to leverage AI to democratize access for small and medium-sized enterprises (SMEs) to established news publications through a pay-on-results model. Founded by Omar Hamdi, the company blends proprietary AI-driven technologies with expert human editorial and strategy teams, partnering with clients to create and distribute high-quality articles across established news outlets, digital platforms and podcast channels. Pathos Communications serves a diversified global client base of more than 6,000 organizations across 89 countries.

Oaklins Cavendish, one of Oaklins’ member firms in the UK, acted as the corporate broker to Pathos Communications on its admission to AIM, raising approximately US$6.7 million through a placing.

“It has been a pleasure to work with Oaklins Cavendish who have delivered a successful IPO for the business I founded. It’s no coincidence that they are the most active UK IPO adviser this year: at every level, they love entrepreneurs and know what it takes to support successful public companies.”

Omar Hamdi

Founder and CEO, Pathos Communications plc

Talk to the deal team

Geoff Nash

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Middlecon has been acquired by Nion
TMT

Middlecon has been acquired by Nion

Middlecon has been acquired by Nion, a digital consultancy backed by Stella Capital. The acquisition strengthens Nion’s capabilities in data management and advanced analytics, enabling it to undertake larger and more complex data-driven initiatives for its customers. The partnership with Nion provides Middlecon with a strong foundation for continued growth and expansion.

Learn more
Backspin has completed a mandatory public tender offer for the shares of Spindox
Private Equity | TMT

Backspin has completed a mandatory public tender offer for the shares of Spindox

Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more